A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastasis Solid Tumors|Advanced Breast Cancer
Interventions: DRUG: XZP-3287
Sponsor: Sihuan Pharmaceutical Holdings Group Ltd.